期刊文献+

前列地尔联合甲钴胺治疗糖尿病周围神经病变的疗效观察 被引量:3

Clinical Analysis on Alprostadil Combined with Mecobalamin for Diabetic Peripheral Neuropathy
原文传递
导出
摘要 目的观察前列地尔联合甲钴胺治疗糖尿病周围神经病变(DPN)的疗效。方法将100例DPN患者随机分成2组,各50例,对照组采用甲钴胺肌内注射,治疗组在对照组用药基础上加用前列地尔静脉滴注,2周后对比2组疗效。结果治疗组改善DPN患者临床症状的总有效率为90%,对照组为64%,差异有统计学意义(P<0.01);周围神经传导速度均有明显改善,但治疗组优于对照组(P<0.05)。结论前列地尔联合甲钴胺治疗DPN可明显提高治疗效果。 [ Objective ] To observe the therapeutic effects of alprostadil combined with mecobalamin for diabetic peripheral neuropathy. [ Methods] 100 patients with diabetic peripheral neuropathy were randomly divided into control group (meeobalamine intramuscular injection) and treatment group ( alprostadil intravenous drip on the basis of control group treatment (. After 2 weeks, the therapeutic effects were compared between the two groups. [ Results ] [ Results ] There was significant difference in the total effective rate of improving clinical symptoms between treatment group (90%) and control group (64% ) ( P 〈 0. 01 ). The peripheral nerve conduction velocity in two groups all had improved, but that in treatment group was better than that in control group significantly ( P 〈 0. 05). [ Conclusion] [ Conclusion] Alprostadil combined with mecobalamin can improve the curative effect of diabetic peripheral neuropathy obviously.
出处 《职业与健康》 CAS 2009年第14期1555-1556,共2页 Occupation and Health
关键词 糖尿病周围神经病变 前列地尔 甲钴胺 Diabetic peripheral neuropathy Alprostadil Mecobalamine
  • 相关文献

参考文献9

  • 1Hartsfield CL, Komer EJ, Ellis JL, et al. Painful diabetic peripheral neuropathy in amanaged care setting:patient identification, prevalence estimates, and pharmacy utilization patterns. Popul Health Manag, 2008, 11:317 -328. 被引量:1
  • 2Putz Z, Nadas J, Jermendy G. Severe but preventable foot burn iniury in diabetic patients with peripheral neuropathy. Med Sci Monit, 2008,14: CS 89 -91. 被引量:1
  • 3朱宪彝主编..临床内分泌学[M].天津:天津科学技术出版社,1993:830.
  • 4方折.现代内科学.北京:人民军医出版社,1996:2733. 被引量:1
  • 5Solano MP, Prieto LM,Varon JC, et al. Ethnic differences in plantar pressures in diabetic patients with peripheral neuropathy. Diabet Med,2008, 25:505 - 507. 被引量:1
  • 6Krupa Shankar DS, Akhib S. Leg ulcers due to hyperhomocysteinemia. Indian J Dermatol Venereol Leprol,2006 ,72 :367 -369. 被引量:1
  • 7Kishida M ,Urakaze M ,Takata M, et al. PGEl inhibits the expression of PAI-1 mRNA induced by TNF-alpha in human mesangial cells. Exp Clin Endocfinol Diabetes ,2005,113:365 - 371. 被引量:1
  • 8赵庆斌,孙超峰,马爱群,崔长琮.前列地尔联合疏血通治疗老年糖尿病周围神经病变的疗效及其机制探讨[J].中国老年学杂志,2008,28(5):506-507. 被引量:12
  • 9李静宜,李强,王薇,孙予倩,梁玮,张巾超.前列地尔脂微球载体注射液对糖尿病下肢动脉血管病变的影响[J].中国实用内科杂志,2007,27(8):597-599. 被引量:38

二级参考文献19

  • 1杨晓凤,吴雁翔,王红梅,许忆峰,吕欣,张轶斌,王法,张悦.自体外周血干细胞移植治疗糖尿病足26例临床研究[J].中国实用内科杂志,2004,24(11):676-678. 被引量:33
  • 2刘颖慧,李红,范慧.2型糖尿病下肢血管病变发生率及危险因素分析[J].中国实用内科杂志,2005,25(9):825-826. 被引量:15
  • 3张璇,肖兵,胡长林.疏血通注射液抗栓、溶栓作用机制的研究[J].中国中药杂志,2005,30(24):1950-1952. 被引量:135
  • 4Acciavatti A,Laghi PF,Capecchi PL,et al.Effects of alprostadil on blood rheology and nucleoside metabolism in patients affected with lower limb chronic ischaemia[J].Clin Hemorheol Microcirc,2001,24(1):49 -57. 被引量:1
  • 5Schror K,Hohlfeld T.Mechanisms of anti-ischemic action of prostaglandin E1 in peripheral arterial occlusive disease[J].Vasa,2004,33(3):119-124. 被引量:1
  • 6Makino H,Aoki M,Hashiya N,et al.Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease,accompanied by up-regulation of hepatocyte growth factor[J].Hypertens Res,2004,27 (2):85-91. 被引量:1
  • 7Weiss T,Fischer D,Hausmann D,et al.Endothelial function in patients with peripheral vascular disease:influence of prostaglandin E1[J].Prostaglandins Leukot Essent Fatty Acids,2002,67 (5):277-281. 被引量:1
  • 8Bandiera G,Forletta M,Di Paola FM,et al.PGE (1) short term therapy in critical lower limb ischemia[J].Int Angiol,2003,22(1):58 -63. 被引量:1
  • 9Okada S,Sato K,Higuchi T,et al.Influence of prostaglandin E1 on slight proteinuria in non-azotaemic diabetics[J].J Int Med Res,1992,20(1):94 -97. 被引量:1
  • 10Rottman M,Koepchen J,Angelkort B.Treating chronic occlusive arterial disease[J].MMW Fortschr Med,2005,147 (18):30-33. 被引量:1

共引文献46

同被引文献23

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部